SCHEMBL24258062

SCHEMBL24258062

Cc1ccc(S(=O)(=O)n2ccc3c(-c4cnn(/C(=C/C#N)C5CCCC5)c4)ncnc32)cc1

nearest known ligand 0.33

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
JAK2 O60674 7/20 0.32
JAK1 P23458 7/20 0.32
CCR6 P51684 1/20 0.31
TYK2 P29597 1/20 0.30
JAK3 P52333 1/20 0.30
BRD4 O60885 1/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30
TSHR P16473 1/20 0.30
CCNA2 P20248 1/20 0.30
CDK2 P24941 1/20 0.30
ACVR1 Q04771 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24258064 1.00 ALDH1A1 (0.33) ALDH1A1L3MBTL1JAK2JAK1CCR6
SCHEMBL24258069 0.86 L3MBTL1 (0.32) L3MBTL1
SCHEMBL24258068 0.78 L3MBTL1 (0.33) L3MBTL1JAK2JAK1TYK2JAK3
SCHEMBL24258065 0.76 JAK2 (0.56) JAK2JAK1CCR6TYK2JAK3
SCHEMBL13243667 0.75 JAK2 (0.33) JAK2JAK1TYK2JAK3
Phosphoric Acid SCHEMBL29378441 0.71 JAK2 (0.59) JAK2JAK1TYK2JAK3
SCHEMBL29837340 0.70 JAK1 (0.61) JAK2JAK1TYK2JAK3
SCHEMBL25035697 0.70 JAK2 (0.32) JAK2JAK1TYK2JAK3
SCHEMBL23322330 0.69 MET (0.47) JAK2JAK3
SCHEMBL4107778 0.68 JAK1 (0.38) L3MBTL1JAK2JAK1TYK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022036030-A1 PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS CONCERT PHARMACEUTICALS, INC. (US) 2022-02-17 WO disclosed